ALGN Stock Recent News

Align Technology commercially launches its Invisalign Palatal Expander System in Turkey after approval from TMMDA.

ROTKREUZ, Switzerland--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that Align's Invisalign Palatal Expander System has been approved by the Turkish Medicines and Medical Device Agency (TMMDA) and is now commercially available in Turk.

Align Technology reports fourth-quarter 2024 revenue growth. This can be mostly attributed to the robust performance of the Imaging Systems & CAD/CAM Services business segment.

Align Technology (ALGN 0.75%), known for its Invisalign clear aligners and digital dental systems, announced its fourth-quarter 2024 results on Feb. 5, 2025. The earnings release highlighted stable performance amid currency and demand challenges.

Although the revenue and EPS for Align Technology (ALGN) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Align Technology (ALGN) came out with quarterly earnings of $2.44 per share, beating the Zacks Consensus Estimate of $2.43 per share. This compares to earnings of $2.42 per share a year ago.

Align Technology, Inc. (NASDAQ:ALGN ) Q4 2024 Earnings Conference Call February 5, 2025 4:30 PM ET Company Participants Shirley Stacy - Vice President, Corporate Communications & Investor Relations Joe Hogan - President & Chief Executive Officer John Morici - Chief Financial Officer Conference Call Participants Michael Cherny - Leerink Partners Elizabeth Anderson - Evercore ISI Glen Santangelo - Jefferies Jon Block - Stifel David Saxon - Needham Jeff Johnson - Baird Brandon Vazquez - William Blair Jason Bednar - Piper Sandler Steven Valiquette - Mizuho Michael Ryskin - Bank of America Erin Wright - Morgan Stanley Operator Greetings. Welcome to the Align Fourth Quarter and Full Year 2024 Earnings Call.

Align Technology forecast its first-quarter revenue below analysts' estimates on Wednesday, signaling soft demand for its clear teeth aligners from teenagers and younger patients.

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today reported financial results for the fourth quarter ("Q4'24") and year ended December 31, 2024 ("2024"). Q4'24 total revenues were $995.2 million, up 1.8% sequentially and up 4.0% year-over-year. Q.

Here is a sneak peek into how five MedTech stocks, BSX, HOLX, TECH, STE and ALGN, are expected to fare in their quarterly results, slated to be released tomorrow.